Literature DB >> 1862777

Congenital atransferrinemia. A case report and review of the literature.

R L Hamill1, J C Woods, B A Cook.   

Abstract

A four-year-old Polynesian girl with a two-year history of severe microcytic, hypochromic anemia (which was refractory to iron therapy) had a decreased beta-globulin fraction on serum protein electrophoresis, resulting from the absence of the transferrin (TRF) band. Subsequent assays for TRF showed a level below the detectable range. Liver biopsy revealed significant deposition of hemosiderin within hepatocytes and Kupffer cells, in addition to early fibrosis. Two bone marrow aspirates were hypercellular, with decreased myeloid-erythroid ratios. This case represents the eighth reported example of congenital atransferrinemia, a rare, apparently autosomal recessive disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1862777     DOI: 10.1093/ajcp/96.2.215

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

Review 1.  Iron and immunity: immunological consequences of iron deficiency and overload.

Authors:  Bobby J Cherayil
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-09-28       Impact factor: 4.291

Review 2.  Forging a field: the golden age of iron biology.

Authors:  Nancy C Andrews
Journal:  Blood       Date:  2008-07-15       Impact factor: 22.113

3.  Late diagnosis of a rare disease.

Authors:  Noha Mohamed El Hossainy
Journal:  BMJ Case Rep       Date:  2009-04-14

Review 4.  Hepcidin and ferroportin: the new players in iron metabolism.

Authors:  Ivana De Domenico; Diane McVey Ward; Jerry Kaplan
Journal:  Semin Liver Dis       Date:  2011-09-07       Impact factor: 6.115

5.  Crosstalk between Iron Metabolism and Erythropoiesis.

Authors:  Huihui Li; Yelena Z Ginzburg
Journal:  Adv Hematol       Date:  2010-06-10

6.  Studies on familial hypotransferrinemia: unique clinical course and molecular pathology.

Authors:  A Hayashi; Y Wada; T Suzuki; A Shimizu
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

7.  Scara5 is a ferritin receptor mediating non-transferrin iron delivery.

Authors:  Jau Yi Li; Neal Paragas; Renee M Ned; Andong Qiu; Melanie Viltard; Thomas Leete; Ian R Drexler; Xia Chen; Simone Sanna-Cherchi; Farah Mohammed; David Williams; Chyuan Sheng Lin; Kai M Schmidt-Ott; Nancy C Andrews; Jonathan Barasch
Journal:  Dev Cell       Date:  2009-01       Impact factor: 12.270

8.  Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis.

Authors:  Yingying Yu; Li Jiang; Hao Wang; Zhe Shen; Qi Cheng; Pan Zhang; Jiaming Wang; Qian Wu; Xuexian Fang; Lingyan Duan; Shufen Wang; Kai Wang; Peng An; Tuo Shao; Raymond T Chung; Shusen Zheng; Junxia Min; Fudi Wang
Journal:  Blood       Date:  2020-08-06       Impact factor: 22.113

Review 9.  Multi-copper oxidases and human iron metabolism.

Authors:  Ganna Vashchenko; Ross T A MacGillivray
Journal:  Nutrients       Date:  2013-06-27       Impact factor: 5.717

10.  Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin.

Authors:  Ivana De Domenico; Diane McVey Ward; Maria Carmela Bonaccorsi di Patti; Suh Young Jeong; Samuel David; Giovanni Musci; Jerry Kaplan
Journal:  EMBO J       Date:  2007-05-31       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.